NCT00311818View on ClinicalTrials.gov

Insulin Glargine in Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2005

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Insulin glargine

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00311818 - Insulin Glargine in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter